OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2
Munazza Shahid, Syed Shahzad‐ul‐Hussan
Journal of Structural Biology (2020) Vol. 213, Iss. 1, pp. 107690-107690
Open Access | Times Cited: 16

Showing 16 citing articles:

Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening
Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Ibrahim M. Ibrahim, et al.
RSC Advances (2021) Vol. 11, Iss. 53, pp. 33380-33398
Open Access | Times Cited: 27

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
Gideon Ampoma Gyebi, Abdo A. Elfiky, Oludare M. Ogunyemi, et al.
Computers in Biology and Medicine (2021) Vol. 136, pp. 104671-104671
Open Access | Times Cited: 23

Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
K. Eurídice Juárez‐Mercado, Milton Abraham Gómez-Hernández, Juana Salinas-Trujano, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 240-240
Open Access | Times Cited: 2

Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease
Daiki Katagishi, Daisuke Yasuda, Kyôko Takahashi, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 80, pp. 129121-129121
Open Access | Times Cited: 7

Repurposing Dyphylline as a Pan-Coronavirus Antiviral Therapy
Yining Wang, Sajjan Rajpoot, Pengfei Li, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 10, pp. 685-699
Open Access | Times Cited: 5

The Molecular Circadian Clock Is a Target of Anti-cancer Translation Inhibitors
Alexandre Berthier, Céline Gheeraert, Manuel Johanns, et al.
Journal of Biological Rhythms (2023) Vol. 39, Iss. 1, pp. 20-34
Open Access | Times Cited: 2

Simple Nano-Luciferase-Based Assay for the Rapid and High-Throughput Detection of SARS-CoV-2 3C-Like Protease
Jingxin Liu, Chenchen Ge, Ling Zha, et al.
Analytical Chemistry (2022)
Closed Access | Times Cited: 4

Comprehensive In silico and In vitro evaluation of Plectranthus amboinicus essential oil: A promising inhibitor of SARS-CoV-2 B.1.1.529 Omicron variant, proinflammatory biomarkers and diabetes-related enzymes
Kristine Mae H. Bonalos, Khent Primo Alcantara, Pornchai Rojsitthisak, et al.
Industrial Crops and Products (2024) Vol. 222, pp. 119905-119905
Closed Access

Malonic Acid-Type Fullerene Derivatives Strongly Inhibit The SARS-Cov-2 Main Protease
Daiki Katagishi, Daisuke Yasuda, Kyoko Takahashi, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Coronavirus (CoV) proteins in GtoPdb v.2023.1
S P H Alexander, Jonathan K. Ball, Theocharis Tsoleridis
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 1
Open Access

Coronavirus (CoV) proteins in GtoPdb v.2023.3
S P H Alexander, Jonathan K. Ball, Theocharis Tsoleridis
IUPHAR/BPS Guide to Pharmacology CITE (2023) Vol. 2023, Iss. 3
Open Access

Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
Gideon Ampoma Gyebi, Abdo A. Elfiky, Oludare M. Ogunyemi, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1

Coronavirus (CoV) proteins in GtoPdb v.2022.2
S P H Alexander, Jonathan K. Ball, Theocharis Tsoleridis
IUPHAR/BPS Guide to Pharmacology CITE (2022) Vol. 2022, Iss. 2
Open Access

Coronavirus (CoV) proteins in GtoPdb v.2022.3
S P H Alexander, Jonathan K. Ball, Theocharis Tsoleridis
IUPHAR/BPS Guide to Pharmacology CITE (2022) Vol. 2022, Iss. 3
Open Access

An Overview of COVID-19 and the Potential Plant Harboured Secondary Metabolites against SARS-CoV-2: A Review
Chidanandamurthy Thippeswamy Swamy
Journal of Pure and Applied Microbiology (2021) Vol. 15, Iss. 3, pp. 1059-1071
Open Access

Coronavirus (CoV) proteins in GtoPdb v.2021.3
S P H Alexander, Jonathan K. Ball, Theocharis Tsoleridis
IUPHAR/BPS Guide to Pharmacology CITE (2021) Vol. 2021, Iss. 3
Open Access

Page 1

Scroll to top